In Brief: Ligand
Executive Summary
Ligand: Andres Negro-Vilar, MD/PhD, to senior VP and chief scientific officer of San Diego-based R&D firm effective Sept. 1. Negro-Vilar comes to Ligand from Wyeth-Ayerst, where he was VP-research and headed the Women's Health Research Institute. Ligand also announces the departure of Senior VP and Chief Scientific Officer Robert Stein, MD/PhD, and VP-Discovery Research David Robertson, who "have resigned to pursue other professional opportunities"...